Publications To Date


    Filter Publications

    PAGE 69 OF 87 | DISPLAYING 1021 - 1035 OF 1293 RESULTS

    Spears M. et al., A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials., [Epub ahead of print]., Oncotarget, Sep 10, 2015

    Magbanua M.J.M. et al., Approaches to isolation and molecular characterization of disseminated tumor cells., [Epub ahead of print]., Oncotarget, Sep 10, 2015

    Quek S-I. et al., Processing of voided urine for prostate cancer RNA biomarker analysis., [Epub ahead of print]., The Prostate, Aug 26, 2015

    Kridel R. et al., Cell of origin of transformed follicular lymphoma, [Epub ahead of print]., Blood, Aug 25, 2015

    Wallden B. et al., Development and verification of the PAM50-based Prosigna breast cancer gene signature assay., , BMC Med Genomics, Aug 22, 2015

    Omuro A. et al., Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma, [Epub ahead of print]., Clin. Cancer Res., Aug 08, 2015

    Chen D.T. et al., Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma., [Epub ahead of print]., PLoS ONE, Aug 06, 2015

    Scott D.W. et al., Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies., [Epub ahead of print]., J. Clin. Oncol., Aug 03, 2015

    Masque-Solar N. et al., Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 - an analysis including gene expression in formalin-fixed paraffin-embedded tissue., [Epub ahead of print]., Br. J. Haematol., Jul 27, 2015

    Jimbo M. et al., Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells., [Epub ahead of print]., Oncotarget, Jul 25, 2015

    Graw S. et al., Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples., [Epub ahead of print]., Sci. Reports, Jul 23, 2015

    Dieras V. et al., Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer., [Epub ahead of print]., Annals of Oncology, Jul 22, 2015

    Shah S.H. et al., Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype., [Epub ahead of print]., Cancer Biology and Ther., Jul 17, 2015

    Yeo B. et al., Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study., [Epub ahead of print]., Br. J. Cancer, Jul 16, 2015

    Topham C. et. al., MYC Is a Major Determinant of Mitotic Cell Fate., [Epub ahead of print]., Cancer Cell, Jul 13, 2015